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Abstract
Cancer remains a leading cause of death in the state of Arkansas and across the
United States. Recent research found that peanuts consumption has been correlated with a
decreased risk of cancer. Although limited research has been conducted, phenolic
antioxidant compounds found in peanuts, arachidin-1 and arachidin-3, are correlated to a
decrease in human leukemia and lung cancer cell growth. The objective of this study was
to evaluate the anti-colon cancer effects of these compounds. Experiments were
conducted to examine the effects of purified arachidin-1 and arachidin-3 on Caco-2 cell
proliferation. Treatment of cells with arachidin-1 (0, 1, 5, 10µM) and arachidin-3 (0, 5,
10, 20µM) were measured at time points 0, 24, and 48 hours. There was cell reduction for
10 and 20µM treatments of arachidin-3 at time point 24 hours, but no other significant
reduction was found. The findings suggest that arachidin-1 and arachidin-3 did not inhibit
the growth of human colon cancer cells. Further research needs to be conducted to
examine the effects of peanuts stilbenoids, arachidin-1 and archidin-3, as potential
anticarcinogenic agents.
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Chapter I. Introduction
Globally, each year about 14 million individuals learn they have cancer while 8
million people die from the disease (CDC, 2014). Cancer is the second leading cause of
mortality in the United States. Colorectal cancer is the third leading cause of cancer death
and approximately 5%, or every 1 in 20 Americans, will be diagnosed with cancer of the
rectum or colon in their lifetime (ACS, 2014). In the state of Arkansas, there is a rate of
41.7 per 100, 000 men and women per year compared to the national rate (42.4 per 100,
000). But Arkansas has a higher death rate (17.9 per 100,000) than the national rate (15.5
per 100,000) (Holt et al., 2011).
Epidemiologic studies have identified an inverse association between diet rich in
fruits and vegetables and cancer (Chen et al., 2015). A variety of fruits and vegetables
contain bioactive components, antioxidants, which have been linked to chemoprevention
of colon cancer (Amin et al., 2009).
Peanuts (Arachis hypogaea L.) contain high concentrations of polyphenolic
antioxidants. Of the bioactive compounds in peanuts much attention has been on the
phenolic antioxidant, resveratrol (trans-3,5,49- trihydroxystilbene), a family of
stilbenoids. Previous research on resveratrol and polydatin (resveratrol-3-O-b-mono- Dglucoside) has indicated that stilbenoid compound polydatin alone or with resveratrol
caused the Caco-2 cell (a human epithelial colorectal adenocarcinoma cell) death by
apoptosis (De Maria et al., 2013). Arachidin-1 [trans-4-(3-methyl-1-butenyl)-3,5,3’,4’tetrahydroxysilbene)], and arachidin-3 [(Arachidin-3, trans-4-(3-methyl-1-butenyl)3,5,4’-trihydroxystilbene)] also belong to a family of stilbenoids derived from the root of
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a peanut plant. However, there is limited information available on health-promoting
activities of arachidin-1 and arachidin-3.
The goal of this study is to determine the effects of arachidin-1 and arachidin-3 on
human colon cancer cells. The objectives of this study were to: 1) determine if arachidin1 and arachidin-3 can inhibit colon cancer cell growth and 2) determine what
concentrations of arachidin-1 and arachidin-3 are effective at inhibiting cell proliferation.
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Chapter II: Literature Review
Colon Cancer
Colorectal cancer is the third most common cancer diagnosed in both men and
women in the United States (NIH, 2016). CRC is cancer that starts in the colon or rectum.
The colon and the rectum are parts of the large intestine, which is the lower part of the
body’s digestive system (CDC, 2014). The function of the colon is to absorb water and
salt from the food matter and to serve as a storage place for waste matter. It is composed
of four different sections: ascending colon, transverse colon, descending colon, and
sigmoid colon (NIH, 2016).
Colorectal cancer incident and mortality rates are dependent on sex, race, age, and
ethnicity (Figure 1). From 2002 to 2011 in the United States the incident rate of
colorectal decreased significantly by 3.6% per year among men and by 3.2% per year
among women. While in the same years, the death rate decreased significantly by 3.1%
per year among men and by 2.9% per year among women (CDC, 2014). Although there
is a decrease, in the United States for 2015 the number of CRC cases was projected to be
132,700 new cases of colon and rectum cancer and 49,700 deaths (NIH, 2016).
Risk factors of colorectal cancer include age, race, sex, heredity, preexisting
conditions and lifestyle factors such as: physical activity, diet, overweight, alcohol
consumption, and tobacco use (CDC, 2014). There is much evidence linking the
‘Western’ diet (high fat and low fiber content) to increased risk of CRC. Diets are under
review as there is a correlation to a higher risk of CRC if a diet consists of a large amount
of red meat or processed meats, but a lower risk of CRC if the diet is high in fruits and
vegetables (NIH, 2016).
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Figure 1: Colorectal Cancer Incident and Mortality Rates* by Race/Ethnicity and Sex,
2006-2010 (ACS, 2014). *Rate are per 100,000

Since diet is a risk factor linked to colorectal cancer, researchers have investigated
whether consuming dietary antioxidants can help lower the risk of developing cancer in
humans. An antioxidant is a chemical substance that slows down or prevents the damage
that oxygen does to organisms or food. Currently research is being conducted looking at
specific antioxidants and the effects on cancer, heart disease, stroke, and other diseases
associated with aging.
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General Information about Peanuts
Nutrients in Peanuts
Peanuts (Arachis hypogaea L.), a type of legume, are known for their source of protein
and energy. For every 100 grams of peanuts there is approximately 585 kilocalories,
21.51 grams of carbohydrates, 8.0g of fiber, and 49.66g of fats, and 23.68g of proteins.
With the exception of meat, legumes, such as peas, beans, and peanuts contain a large
amount of protein, more than any other nuts (Settaluri et al., 2012). Peanuts are composed
of nutrients, minerals, and vitamins that are essential for optimum health.
Table 1. Composition by weight* of biomolecules in peanuts (Adapted from Settaluri et
al., 2012)
Amino acids
Vitamins
Type
Tryptophan
Threonine
Isoleucine
Leucine
Lysine
Methionine
Cysteine
Phenylalanine
Tyrosine
Valine
Arginine
Histidine
Alanine
Aspartic acid
Glutamic acid
Glycine
Proline
Serine

Weight (g)*
0.230
0.811
0.833
1.535
0.850
0.291
0.304
1.227
0.963
0.993
2.832
0.599
0.941
2.888
4.949
1.427
1.045
1.167

Lipids
Total saturated fatty acid
Total monounsaturated
Total polyunsaturated

Type
Thiamin
Riboflavin
Niacin
Pantothenic acid
B6
Folate
E**
Choline

Weight (g)*
0.438x10-3
0.098x10-3
13.525x10-3
1.395x10-3
0.256x10-3
1450x10-6
6.93x10-3
55.3x10-3

Minerals
Calcium
Iron
Magnesium
Phosphorous
Potassium
Sodium
Zinc
Manganese

54x10-3
2.26x10-3
176x10-3
358x10-3
658x10-3
6x10-3
3.31x10-3
2.083x10-3

Others
6.893
24.640
15.694

Carbohydrates (total)
Dietary fiber
Sugar (total)

21.51
8.0
4.18

*Quantities expressed are per 100g of dry-roasted peanuts, all types, and without salt. **This is a fat
soluble vitamin and the rest are water soluble vitamins
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Peanuts dietary protein contains amino acids essential for growth and development.
Additionally, they are great sources of folate, manganese, niacin – which contributes to
brain health and blood flow to brain, and vitamin E – a powerful lipid solvent
antioxidant.
Health Benefits of Peanuts
Peanuts are one of the widely cultivated oil-seed and established prime
commercial crops in the world. The health benefits of peanuts are becoming a rising topic
for researchers as well as nutritionists. In recent years, research has shown that peanuts
could be linked to reduced weight gain and especially correlated with different functions
in the digestive system (Bes-Rastrollo et al., 2007). Women age 30-55 years had no
history of gallstone disease was studied in a 20-year cohort study. Women who consumed
at least one ounce of peanuts and/or other nuts each week had a significantly lower risk of
cholecystectomy than women who did not eat nuts (Tsai et al., 2004). In a different
cohort study of 8,866 individuals, it was found that those who ate nuts—walnuts,
almonds, hazelnuts, and peanuts— at least twice a week were much less likely to gain
weight of 5 kilograms or more than those who almost never ate nuts (Bes-Rastrollo et al.,
2007). In another 10-year cohort study beginning in 1990, the consumption of peanuts
and a reduced risk of colorectal cancer were correlated. 12,026 men and 11,917 women
aged 30 to 65 years, who were residents in 7 townships in Taiwan, were annually
followed by evaluating weekly food measures. Their findings suggest that women who
consumed peanuts had a much lower risk of colorectal cancer. It is indicated that some
specific components in peanuts inhibit the carcinogenic mechanisms of colorectal cancer,
but other studies must be conducted in order to rule out other factors that might have been
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present (Yeh et al., 2006). A following step could be to determine what specific
component(s) do peanuts possess that could be linked to one or more of these
advancements in human health mentioned above. Recent discovery of bioactive
components in naturally occurring food has allowed research to continue to conduct more
specific studies by researching one or more of the components in food directly. The
ability to test only certain bioactive components are crucial for both the research of food
industries as well as research regarding human biological processes and diseases. As
mentioned above, there are many studies correlating health benefits and peanuts. With
increased research with certain bioactive components experimenters can see more
specific correlations and possibly extend information to other areas especially for human
health.
Bioactive Components in Peanuts
Bioactive compounds are extra nutritional constituents that typically occur in
small quantities in foods (Kris-Etherton et al., 2002). Currently bioactive components
(which are varied by the number of hydroxyl groups and isopentenyl moiety) in peanuts
are on the forefront of research as they are able to prevent or slow the growth of cancers,
contain antioxidants, and even extend lifespans (Chang et al., 2006). Polyphenols,
antioxidants, are abundant in fruits and vegetables, and evidence for their role in the
prevention of degenerative diseases such as cancer and cardiovascular diseases is
emerging (Manach et al., 2004). The health effects of polyphenols depend on the amount
consumed and on their bioavailability (Manach et al., 2004). Not only do polyphenols
have antioxidant properties, but also they have other have a variety of biological activities
that are yet to be understood (Manach et al., 2004). Polyphenols are composed of a
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subcategory named natural stilbenoids, which are a family of polyphenols known for
their diverse biological activities. Recently, it was found that the stilbenoid antioxidants
and resveratrol (trans-3,5,4’- trihydroxystilbene), found in peanuts seeds and red grapes
has been determined to improve blood flow in the brain by as much as 30%, thus greatly
reducing the risk of stroke (Peanuts, 2015). Previous research on polydatin, (resveratrol3-O-b-mono- D-glucoside, Product Origin: Root of Polygonum cuspidatum), a natural
precursor of resveratrol, reported that polydatin alone or with resveratrol caused the
Caco-2 cell (a human epithelial colorectal adenocarcinoma cell) death by induction of
apoptosis (De Maria et al., 2013). Although resveratrol (trans-3,5,4’- trihydroxystilbene)
has received considerable attention as a putative anticancer agent, a study found that
other peanuts prenylated stilbenoids, arachidin-1 and archidin-3, may be preferable
alternatives due to increased bioavailability via slowed metabolism (Brents et al., 2012).
Due to the similar chemical structures of resveratrol, arachidin-1 (trans-4-(3-methyl-1butenyl)-3,5,3’,4’-tetrahydroxysilbene), and arachidin-3 (Arachidin-3, trans-4-(3-methyl1-butenyl)-3,5,4’-trihydroxystilbene) are now specifically being studied. Arachidin-1 and
arachidin-3 belong to a family of stilbenoids derived from the root of a peanuts plant.
Current research is limited due to the recent discovery of these bioactive components.
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Figure 2. Chemical Structures of 1. Resveratrol (trans-3,5,4’- trihydroxystilbene) 2.
Arachidin-1 trans-4-(3-methyl-1-butenyl)-3,5,3’,4’-tetrahydroxysilbene; 3. Arachidin-3,
trans-4-(3-methyl-1-butenyl)-3,5,4’-trihydroxystilbene (Adapted from Soboley 2013).

Biological Activities of Arachidin-1 and Arachidin-3
Prenylated stilbene compounds in peanuts such as arachidin-1 (Ara-1) and
arachidin-3 (Ara-3) are beginning to be studied in vitro experiments in order to
understand these compounds and the functions that they possess. It was found that both
of these compounds possess a defense mechanism against physical injuries and fungal
contamination when challenged by a fungal strain (Liu et al., 2013). Prenylated Ara-1 and
Ara-3 improved glucuronidation profiles (Brents et al., 2012). In addition, both Ara-1 and
Ara-3 showed a significant decrease in Rotavirus Gastroenteritis viral replication when
applied (Ball et al., 2015). This study found that the effects of the compounds, Ara-1 and
Ara-3, were dose- and time- dependent to decrease viral progeny when they were applied
to both the Rotavirus within human intestinal cells. It is indicated that the prenylated side
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chain of Ara-1 and Ara-3 promotes invasion through cell membranes more than
resveratrol due to the increased lipophilicity to the attached molecules (Ball et al., 2015).
Compounds, Ara-1 and Ara-3, are being used in a variety of experiments with viruses,
fungal strains, and possible therapeutic values for chronic disease, but they are commonly
used in exposure to cancer cells. (Liu et al., 2013). In recent studies Ara-1 had the highest
efficacy in inducing programed cell death in Human Leukemia cells HL-60 with an
approximately 4-fold lower EC50 than resveratrol. Specifically Ara-1 caused
mitochondrial membrane damage, released apoptosis-inducing factor, and activation of
caspases (Huang et al., 2010). Ko and colleagues in 2013, reported that arachidin-1
decreased thymidine phosphorylase (TP) and Excision repair cross-complementation 1
(ERCC1), both with high amounts in cancer cells are associated with poor prognosis. In
addition, arachidin-1 combined with Metformin, a type two diabetic drug, significantly
decreased TP and ERCC1 in human lung cancer (NSCLC) cell lines (Ko et al., 2013).

Table 2. Summary of anticarcinogenic activities of arachidin-1 arachidin-3, and
resveratrol (in vitro studies).
Phenolic
Compound
Resveratrol,
Polydatin
(De Maria et
al., 2013)

Cell Line

Concentration Effect

Time

Caco-2 cells,
differentiated
and
undifferentiated

Different
concentrations:
0 to 500µM of
each or
combination
(50:50, 75:25
molar ratio)

24 hours
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IC50: 190µM
Pol and 373µM
Res in
differentiated
polydatin alone
has a stronger
cytotoxicity,
antiproliferative
effect poly:res
3:1

Phenolic
Compound
Arachidin-1,
Arachidin-3,
Resveratrol
(Cheng-Po et
al., 2010)
Metformin
(diabetic
drug),
Arachidin-1
(Ko et al.,
2013)

Arachidin-1
Arachidin-3
Resveratrol
Piceatannol
(Ball et al.,
2015)

Cell Line

Concentration Effect

Time

Human
leukemia HL60

0 to 20 µM
treating with
Ara-1 and Ara3

0-72 hours

A549 and
H1975 Lung
cancer cells

0.5, 1, 5 and
10 µM Ara-1
and 25 µM
metformin

EC50 values of
4.2 µM Ara-1,
18.9 µM Ara-3,
and 17.6 µM
resveratrol
Greater loss of
cell viability
with both
metformin and
Ara-1

Ara-1 10 µM
tenfold
decrease, 20
µM twentyfivefold
decrease
Ara-3 10 µM
ninefold
decrease, 20
µM ninetyeightfold
decrease
in virus
infectivity titer

12 and 24
hours
postinfection

Treated with
metformin,
Ara-1 or both
for 24hr

5, 10, 25 and
50 µM
metformin and
0.5µM Ara-1

Rotavirus
Gastroenteritis
HT29 (Human
intestinal line
infected with
Rotavirus)

Ara-1 (0.5
µM) were
added for 24 hr
10, 20 µM
Ara-1,
10, 20 µM
Ara-3

*IC50: the dose that causes half-maximal inhibition by antagonist
** EC50: the concentration resulting in a 50% decrease in cell viability (Cheng-Po et al.,
2010)
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Chapter III: Materials and Methods
Materials
Arachidin-1 (Ara-1) and arachidin-3 (Ara-3) compounds were generously donated
by Dr. Medina-Bolivar (Arkansas State University, Jonesboro, AR). All media
components and reagents were obtained from Gibco® through ThermoFisher (Waltham,
MA).

Methods
HPLC Analysis
A System Gold high performance liquid chromatograph (Beckman-Coulter,
Fullerton, CA, USA) with autosampler (model 508), dual pump (model 126), photodiode
array detector (model 168) with Beckman-Coulter System 32 Karat software (version 8,
2006) was used to analyze the arachidin-1 and arachidin-3. The compounds were
separated using an adapted method of Abbott et al (2010). Separation was performed
using a Phenomenex (Torrance, CA) Aqua 5µm C18 (250 × 4.6 mm) column using a
binary gradient of 2% formic acid for mobile phase A and 99:1 (v/v) acetonitrile/mobile
phase A. The initial conditions of the gradient were 10% B, then increased linearly from
10-18% for 8 min, and was held at 18% B for 2 minutes. Next, B increased linearly to 1825% over 5 min, 25-35% B for 3 min, and held isocratically for 20 min, then %B
increased 35-60% linearly for 60 min before returning to the initial 10%B. Peaks were
monitored at 340 nm refer to Figure 3.
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Cell Culture
A human epithelial colorectal adenocarcinoma cell line (Caco-2 cells) was
purchased from the American Type Culture Collection (ATCC, Rockville, MD). The
cells were at passage number 18 (passage number refers to the number of times the cell
line has been re-plated) and cultured in Working Media (W-MEM). W-MEM is
composed of 10% fetal bovine serum (FBS), 2% antibiotic-antimicotic solution, 1% Nonessential amino acids, and Dulbecco’s modified eagle’s medium (DMEM). Cell cultures
were maintained under strict sterile conditions incubated at 37°C, 70% humidity, and 5%
CO2 in the incubator (VWR® symphony ™, VWR® International LLC, Radnor, PA).
Cell Proliferation Assay
Cells, passage number 22-25, were used for the proliferation assays. The effects
of Ara-1 and Ara-3 on the cellular proliferation and viability of Caco-2 cells were
measured using CellTiter 96® Aqueous One Solution Proliferation Assay (Promega Cor.
Madison, WI). CellTiter 96® contains tetrazolium compound [3-(4,5-dimethyl-2-yl)-5(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS] and an
electron coupling reagent (phenazine ethosulfate; PES). This assay is a colorimetric
method to determine the number of viable cells in proliferation or cytotoxicity assays.
The tetrazolium compound becomes reduced by living cells into a colored formazan
product, which is soluble in culture media. The amount of reduced tetrazolium is
measured by a plate reader resulting in a directly proportional number of living cells in
the culture.
To conduct this MTS assay, Caco-2 cells (2 x 103) in 200µl of W-MEM were
seeded in the wells of a 96 well plate. Cells were incubated at 37°C, 70% humidity, and
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5% CO2 for 24 hours to allow attachment of the cells to the bottom of the wells. After 24
hours, the media was aspirated and replaced with different concentrations of a compound
(either Ara-1 or Ara-3) and control. Treatment media containing Ara-1 at concentrations
of 1, 5, and 10µM and Ara-3 at concentrations of 5, 10, and 10µM. A negative control of
0.1% DMSO in 10% FBS W-MEM was used to measure the viability of Caco-2 cells in
the absence of compounds. Treatments and negative controls were done in triplicate.
Viability measurements were made at time 0hr, 24hr, and 48hr after the addition of the
compounds or control. Time 0hr refers to the time of applying treatment.
CellTiter reagent was directly added to the cells, 40µl per well. The reagent was
added to all wells (including wells with cells and to wells only with compounds where no
cells are present, a sample control). Microplates were incubated for 2 hours after the
addition of the reagent, before measuring the absorbance at 490nm with the plate reader
(Synergy HT Multi-Mode Microplate Reader, BioTek Instruments, Inc. Winooski, VT).
Once the absorbance readings were made, data was corrected for the background
absorbance of the wells with negative control media or with wells with compounds
without cells. Corrected absorbance numbers were converted into cell numbers using an
equation from the Caco-2 cell standard curve.
A standard curve was composed of serial dilution of cells prepared in triplicate in
a 96 well plate ranging from 32000 cells to 0 cells with W-MEM. The standard curve was
created by seeding cells in the actual experiment adding CellTiter reagent directly to the
wells, and then measuring the absorbance of these cells. The results of standard curve of
the 0hr plate were plotted to compare the change in absorbance as the total cell number
increased. Each experiment conducted used the equation given from data plotted to
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calculate the cell numbers to plot cell growth curves. Cell viability was checked at time
points of 24hr and 48hr with cell counts ranging from 32000 to 2000.
Statistical Analysis
Values were expressed means ± standard error of the mean (SEM). Data was
analyzed using Statistical Analysis System (Version 9.4; SAS Institute Inc., Cary, NC). A
one-way analysis of variance was used to show significant differences from the control
cells at each time point. An alpha level of 0.05 was used to determine statistically
significant differences. Fisher’s least significant difference (LSD) test was used to
analyze the data.
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Chapter IV: Results
HPLC Results
The High Performance Liquid Chromatogram (HPLC) analysis confirmed the
identity of compounds used for this experiment: arachidin-1 and arachidin-3. The results
are summarized in Figure 3.

Arachidin 3

Arachidin 1

Figure 3. High Performance Liquid Chromatogram of arachidin-1 and arachindin-3 at
340nm.

Cell Standard Curve
In order to differentiate outside factors from treatment cells, a standard curve was
used as a control on every plate. This was used as a reference for cell growth and
conditions on each cell plate throughout the experiment. Figure 4 shows the standard
curve of Caco-2 cells.
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1.800
1.600

y = 5E-05x + 0.1143
R² = 0.99051

Absorbance (490nm)

1.400
1.200
1.000
0.800
0.600
0.400
0.200
0.000
0

5000

10000

15000

20000

25000

30000

35000

Cell number

Figure 4. Caco-2 cell standard curve

Cell Proliferation
Treatment of Caco-2 Cells with arachidin-1 did not decrease cell proliferation
compared to control (Figure 5). There is a difference between 10mM cell growth
compared to the control (0µM), 1µM, and 5µM. At both time points of 24 and 48 hours
for arachidin-1, 10µM treatment seemed to promote cell growth compared to the control,
treatment of 1µM and 5µM. The effectiveness of reduced cell proliferation for arachin-1
was not correlated with concentration at time points 24 and 48 hours.
Figure 6 shows the effects of arachidin-3 on the survival of Caco-2 cells.
Compared with the control and 5µM of arachidin-3, treatments of 10µM and 20µM of
arachidin-3 resulted in a significant reduction of cell number at time point 24 hours
(P<0.05). At time point 48 hours there was not a significant difference between the any of
the treatments of arachidin-3.
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50000
Control
a

A1- 10µM
10mM

40000

Cell number

A1- 5µM
5mM

b

A1-1µM
1mM

30000

b
a

20000

b
b

10000

0
0h

24h

48h

Time

Figure 5. Effect of arachidin-1 on the survival of Caco-2 cells. Values are
mean + standard error of the mean (SEM). Values with different letters at the
same incubation time are significantly different (P<0.05).

35000
Control
30000

A3- 20µM
20mM
A3- 10µM
10mM

Cell number

25000

A3- 5µM
5mM
20000

a
a

15000

b

b

10000
5000
0
0h

24h

48h

Time

Figure 6. Effect of arachidin-3 on the survival of Caco-2 cells. Values are
mean + standard error of the mean (SEM). Values with different letters at the
same incubation time are significantly different (P<0.05).
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Chapter V: Discussions
Peanuts (Arachis hypogaea L.) contain many nutrients, antioxidants, vitamins,
and minerals essential to optimal health (Settaluri et al., 2012). Peanuts have been linked
to reduced weight gain to reduced risk of heart disease (Bes-Rastrollo et al., 2007;
Settaluri et al., 2012).
The present study investigated the effects of stilbenoids (arachidin-1 and
arachidin-3) found in peanuts root on colon cancer cells (Caco-2 cells) proliferation. No
significant reduction of cell growth with arachidin-1. There was a significant increase of
proliferation at time point 24 and 48 hours for 10µM treatment of arachidin-1. However,
there was a significant difference in inhibition of cell growth for treatments 10µM and
20µM of arachidin-3, but none of the treatments showed a significant difference at time
point 48 hours. Further research should include higher concentrations of arachidin-1 and
arachidin-3 on Caco-2 cell growth.
There have been a few in-vitro studies regarding the anti-proliferative behavior of
arachidin-1 and arachidin-3, but there is a variation in results and concentrations of these
compounds between studies. These studies have reviewed different cells lines and
combined alternative drugs or naturally occurring compounds combined with arachidin-1
and arachidin-3 (De Maria et al., 2013, Cheng-Po et al., 2010, Ko et al., 2013, Ball et al.,
2015). There was only one study found to look at Caco-2 cells combining antioxidant
agents, resveratrol and Polydatin (De Maria et al., 2013). Due to the limited research of
compounds arachidin-1 and arachidin-3 effects on Caco-2 cells, there could be a different
concentration needed to inhibit proliferation. A study on human leukemia cell line

22

suggested that arachidin-1 should be more potent than arachidin-3, but this study was not
able to concur with these results (Cheng-Po et al., 2010). Based on previous studies
concentrations of treatments varies depending on cell line experimented (De Maria et al.,
2013, Cheng-Po et al., 2010). Due to the limited research with Caco-2 cell line with
peanuts stilbenoids more research need to be conducted to fully understand the effects of
these compounds.
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Chapter IV: Conclusions
The results of the present study suggest that arachidin-1 and arachidin-3 did not
inhibit the growth of human colon cancer cells. In order to understand the biological
activities of these compounds more studies need to be conducted.
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